Performance of (18)fluorodeoxyglucose-positron emission tomography and somatostatin receptor scintigraphy for high Ki67 (≥10%) well-differentiated endocrine carcinoma staging

The purpose of this prospective study was to compare the performance of (111)In-octreotide somatostatin receptor scintigraphy (SRS) and (18)fluorodesoxyglucose positron emission tomography (FDG-PET) in aggressive well-differentiated endocrine carcinoma (WDEC) defined by a high Ki67 (≥10%). Eighteen...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The journal of clinical endocrinology and metabolism 2011-03, Vol.96 (3), p.665-671
Hauptverfasser:	Abgral, Ronan, Leboulleux, Sophie, Déandreis, Désirée, Aupérin, Anne, Lumbroso, Jean, Dromain, Clarisse, Duvillard, Pierre, Elias, Dominique, de Baere, Thierry, Guigay, Joël, Ducreux, Michel, Schlumberger, Martin, Baudin, Eric
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Cell Proliferation Endocrine Gland Neoplasms - diagnostic imaging Endocrine Gland Neoplasms - pathology Female Fluorodeoxyglucose F18 Humans Image Processing, Computer-Assisted Ki-67 Antigen - metabolism Male Middle Aged Neoplasm Staging - methods Positron-Emission Tomography Radiopharmaceuticals Receptors, Somatostatin - metabolism Somatostatin - analogs & derivatives Survival Analysis Tomography, X-Ray Computed
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!